Medicare billing address
CMS Medicare provider billing file
325 Central Ave Ste 200Malvern, PA 19355
CMS public data · NPI 1902196801
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Robert Frankel, M.D.
Specialty
Credential
M.D.
NPI
1902196801
Primary source state
PA
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Robert Frankel, M.D. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
325 Central Ave Ste 200CMS Doctors & Clinicians file
2112 Harrisburg PikeIn the 2024 CMS provider billing file, this NPI had 570 Medicare beneficiaries and 13,547 total services. The average beneficiary age was 75, and the average HCC risk score was 1.3.
Total Medicare allowed amount
$305,172.37
Total Medicare payment amount
$243,510.46
Medicare beneficiaries
570
Total services
13,547
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
69%
CMS beneficiary-panel share
Ischemic heart disease
38%
CMS beneficiary-panel share
Anxiety
26%
CMS beneficiary-panel share
Chronic kidney disease
24%
CMS beneficiary-panel share
Diabetes
24%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, vedolizumab, intravenous, 1 mg | 5,100 | $21.95 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 191 | $255.12 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 90 | $93.09 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 89 | $131.88 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 76 | $98.25 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 49 | $50.00 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 48 | $131.20 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 32 | $83.73 |
| Biopsy of large bowel using a flexible endoscope | 29 | $105.89 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 29 | $178.70 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1902196801. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Pantoprazole Sodium | Pantoprazole Sodium | 117 | 256.5 | $1,430.20 |
| 2 | Omeprazole | Omeprazole | 92 | 202 | $1,287.67 |
| 3 | Mesalamine | Mesalamine | 55 | 95 | $14,953.97 |
| 4 | Stelara | Ustekinumab | 31 | 55.3 | $900,826.27 |
| 5 | Balsalazide Disodium | Balsalazide Disodium | 29 | 65 | $5,286.48 |
| 6 | Trulance | Plecanatide | 25 | 27 | $14,926.62 |
| 7 | Cholestyramine | Cholestyramine (With Sugar) | 19 | 31 | $850.90 |
| 8 | Creon | Lipase/Protease/Amylase | 15 | 22.5 | $47,959.80 |
| 9 | Ciprofloxacin Hcl | Ciprofloxacin Hcl | 14 | 14 | $114.61 |
| 10 | Lansoprazole | Lansoprazole | 14 | 28 | $574.16 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Jefferson Medical College Of Thomas Jefferson University
Graduation year
2011
Group/practice field
Regional Gastroenterology Associates Of Lancaster, Ltd.
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.